Fragasso Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $558K | Buy |
1,254
+143
| +13% | +$63.7K | 0.04% | 176 |
|
|
2025
Q1 | $539K | Sell |
1,111
-239
| -18% | -$116K | 0.04% | 170 |
|
|
2024
Q4 | $544K | Sell |
1,350
-33
| -2% | -$13.3K | 0.04% | 158 |
|
|
2024
Q3 | $643K | Buy |
1,383
+24
| +2% | +$11.2K | 0.05% | 149 |
|
|
2024
Q2 | $637K | Buy |
1,359
+30
| +2% | +$14.1K | 0.05% | 145 |
|
|
2024
Q1 | $556K | Sell |
1,329
-600
| -31% | -$251K | 0.05% | 152 |
|
|
2023
Q4 | $785K | Buy |
1,929
+5
| +0.3% | +$2.03K | 0.07% | 130 |
|
|
2023
Q3 | $669K | Buy |
1,924
+8
| +0.4% | +$2.78K | 0.07% | 126 |
|
|
2023
Q2 | $674K | Buy |
1,916
+53
| +3% | +$18.7K | 0.07% | 128 |
|
|
2023
Q1 | $587K | Buy |
+1,863
| New | +$587K | 0.07% | 129 |
|